Molecular Diagnosis & Therapy

Molecular Diagnosis & Therapy

分子诊断与治疗

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Molecular Diagnosis & Therapy》是由Springer International Publishing出版社于2000年创办的英文国际期刊(ISSN: 1177-1062,E-ISSN: 1179-2000),该期刊长期致力于遗传学领域的创新研究,主要研究方向为药学-医学。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA未开放获取模式(OA占比0.1908...%),以发表遗传学领域等方向的原创性研究为核心(研究类文章占比64.81%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在54篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Molecular Diagnosis & Therapy审稿周期约为 12周,或约稿 。该刊近年未被列入国际预警名单,年发文量约54篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 54 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
GENETICS & HEREDITY 遗传学 PHARMACOLOGY & PHARMACY 药学
3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
GENETICS & HEREDITY 遗传学 PHARMACOLOGY & PHARMACY 药学
3区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GENETICS & HEREDITY SCIE Q1 39 / 191

79.8%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 78 / 354

78.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GENETICS & HEREDITY SCIE Q2 59 / 191

69.37%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 98 / 354

72.46%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.8 SJR:1.214 SNIP:0.949
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Genetics Q1 77 / 347

77%

大类:Biochemistry, Genetics and Molecular Biology 小类:Pharmacology Q1 77 / 313

75%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Medicine Q2 53 / 178

70%

期刊发文

  • Genetic Profiling of Diffuse Large B-Cell Lymphoma: A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor Lymphoma

    Author: Chen, Haizhu; Qin, Yan; Liu, Peng; Yang, Jianliang; Gui, Lin; He, Xiaohui; Zhang, Changgong; Zhou, Shengyu; Zhou, Liqiang; Yang, Sheng; Shi, Yuankai

    Journal: MOLECULAR DIAGNOSIS & THERAPY. 2023; Vol. 27, Issue 1, pp. 75-86. DOI: 10.1007/s40291-022-00621-2

  • Emerging Landscape of SARS-CoV-2 Variants and Detection Technologies

    Author: Li, Xianghui; Wang, Jing; Geng, Jingping; Xiao, Liming; Wang, Hu

    Journal: MOLECULAR DIAGNOSIS & THERAPY. 2023; Vol. 27, Issue 2, pp. 159-177. DOI: 10.1007/s40291-022-00631-0

  • The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis

    Author: Wu, Yanan; Hong, Qiwei; Lu, Fang; Zhang, Zhongqiu; Li, Jingjing; Nie, Zhenlin; He, Bangshun

    Journal: MOLECULAR DIAGNOSIS & THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40291-023-00641-6

  • The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications

    Author: Jiao, Zhuoya; Pan, Yunxia; Chen, Fengyuan

    Journal: MOLECULAR DIAGNOSIS & THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40291-023-00645-2

  • A Review of CRISPR-Based Advances in Dermatological Diseases

    Author: Lu, Xinyi; Jin, Hongzhong

    Journal: MOLECULAR DIAGNOSIS & THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40291-023-00642-5

  • Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma

    Author: Jianing Xu, Neil Gross, Yuanwei Zang, Shengda Cao, Feilong Yang, Zheng Yang, Wenbin Yu, Dapeng Lei, Xinliang Pan

    Journal: Molecular Diagnosis & Therapy, 2019, Vol., , DOI:10.1007/s40291-019-00393-2

  • Clinicopathological Features of <Emphasis Type="Italic">ALK</Emphasis> Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis

    Author: Ruiying Zhao, Jie Zhang, Yuchen Han, Jinchen Shao, Lei Zhu, Chan Xiang, Qing Zhang, Haohua Teng, Gang Qin, Lanxiang Zhao, Min Ye, Jikai Zhao, Wenjie Ding

    Journal: Molecular Diagnosis & Therapy, 2019, Vol., , DOI:10.1007/s40291-019-00389-y

  • Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer

    Author: Kai Tao, Shipeng Guo, Rui Chen, Chengcheng Yang, Lei Jian, Haochen Yu, Shengchun Liu

    Journal: Molecular Diagnosis & Therapy, 2019, Vol.23, 127-138, DOI:10.1007/s40291-019-00384-3